Article
IGF2 associated PI3K signaling shapes temozolomide sensitivity in glioblastoma
2026-03-08
Abstract excerpt
<title>Abstract</title> <p> Resistance to temozolomide (TMZ) remains a major obstacle in glioblastoma (GBM) therapy and cannot be fully explained by canonical DNA repair mechanisms alone. Here, by integrating large scale transcriptomic datasets with machine learning based prioritization and functional validation, we identify insulin-like growth factor 2 (IGF2) as a key molecular hub linking tumor metabolic repro...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 66c2d85f-e74a-51e9-9fce-e79aae6be11b
- DOI
- 10.21203/rs.3.rs-8542364/v1
